dacarbazine has been researched along with ACTH-Producing Pituitary Adenoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assié, G; Batisse-Lignier, M; Bonnet, F; Borot, S; Bourcigaux, N; Bresson, D; Caron, P; Castinetti, F; Chabre, O; Chanson, P; Cloix, L; Cortet, C; Delemer, B; Desailloud, R; Gaillard, S; Garcia, C; Haissaguerre, M; Jouanneau, E; Jublanc, C; Lasolle, H; Lebrun-Frenay, C; Raverot, G; Reznik, Y; Sadoul, JL; Taillandier, L; Vasiljevic, A; Villa, C | 1 |
| Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Kluczyński, Ł; Pach, D; Pantofliński, J; Sokołowski, G; Sowa-Staszczak, A; Turek-Jabrocka, R; Wilusz, M; Zieliński, G | 1 |
| Bruce, JN; Carminucci, AS; Fine, RL; Gulati, AP; Lignelli, A; Remotti, H; Siegelin, M; Wardlaw, SL; Zacharia, BE | 1 |
| Jouanneau, E; Raverot, G; Trouillas, J | 1 |
| Ambrosi, B; Corbetta, S; Mendola, M; Passeri, E | 1 |
| Bruno, OD; Christiansen, SB; Danilowicz, K; Juárez-Allen, L | 1 |
| Aller, J; Campderá, M; Estrada, J; Lilienfeld, H; Magallón, R; Martín, P; Palacios, N; Saucedo, G | 1 |
| Denew, P; Kurowska, M; Maksymowicz, M; Malicka, J; Tarach, JS; Zieliński, G | 1 |
| Bruce, JN; Fine, RL; Freda, PU; Isaacson, SR; Lee, Y; Thearle, MS | 1 |
| Assaker, R; Bernier, M; Borson-Chazot, F; Brue, T; Caron, P; Chabre, O; Chanson, P; Cornélius, A; Cortet-Rudelli, C; de Fraipont, F; Dufour, H; Figarella-Branger, D; François, P; Gaillard, S; Jouanneau, E; Muller, M; Passagia, JG; Raverot, G; Salenave, S; Sturm, N; Trouillas, J | 1 |
| Delashaw, JB; Dillard, TH; Fleseriu, M; Gultekin, SH; Neuwelt, EA; Yedinak, CG | 1 |
| Drake, WM; Horvath, E; Kovacs, K; Manoranjan, B; Moyes, VJ; Salehi, F; Scheithauer, BW; Sharma, S; Syro, LV | 1 |
| Ersen, A; Fadul, CE; Horvath, E; Kovacs, K; Ortiz, LD; Rotondo, F; Scheithauer, BW; Syro, LV; Uribe, H | 1 |
| Annamalai, AK; Antoun, NM; Burnet, NG; Burton, H; Cheow, HK; Dean, AF; Gurnell, M; Halsall, DJ; Jefferies, SJ; Kandasamy, N; Kirollos, RW; Kovacs, K; Pickard, JD; Shaw, AS; Simpson, HL | 1 |
3 review(s) available for dacarbazine and ACTH-Producing Pituitary Adenoma
| Article | Year |
|---|---|
Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide | 2018 |
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Follicle Stimulating Hormone; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Luteinizing Hormone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Temozolomide; Thyrotropin | 2014 |
Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Humans; Liver Neoplasms; Male; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Temozolomide | 2012 |
11 other study(ies) available for dacarbazine and ACTH-Producing Pituitary Adenoma
| Article | Year |
|---|---|
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Chemoradiotherapy; Cohort Studies; Dacarbazine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; France; Humans; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Practice Patterns, Physicians'; Prolactinoma; Retrospective Studies; Survival Analysis; Temozolomide; Tumor Burden | 2017 |
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide | 2014 |
Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Dacarbazine; Humans; Male; Middle Aged; Temozolomide | 2014 |
Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary ACTH Hypersecretion; Remission Induction; Temozolomide; Treatment Outcome; Tumor Burden | 2015 |
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Humans; Hydrocortisone; Male; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Temozolomide; Treatment Failure | 2016 |
Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Dacarbazine; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide; Treatment Outcome | 2016 |
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Invasiveness; Radiography; Temozolomide; Treatment Outcome | 2011 |
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; DNA Methylation; Female; France; Humans; Male; Middle Aged; Neoplasm Invasiveness; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sequence Analysis, DNA; Temozolomide | 2010 |
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
Topics: ACTH-Secreting Pituitary Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Middle Aged; Ophthalmoplegia; Pituitary Neoplasms; Temozolomide | 2011 |
Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nelson Syndrome; Temozolomide; Tumor Suppressor Proteins | 2010 |
Anti-VEGF therapy in pituitary carcinoma.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Positron-Emission Tomography; Temozolomide; Vascular Endothelial Growth Factor A | 2012 |